News | Virtual and Augmented Reality | January 20, 2023

Realize Medical Receives FDA Clearance For Virtual Reality Surgical Planning Software

Healthcare software start-up, Realize Medical, announced today that its virtual reality (VR) software for surgical planning, Elucis, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

January 20, 2023 — Healthcare software start-up, Realize Medical, announced today that its virtual reality (VR) software for surgical planning, Elucis (ee-loo-sis), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). 

“As one of the younRealgest companies in the mixed reality space, FDA clearance is a significant milestone – allowing us to transform our advanced and leading VR software into real benefits for physicians and their patients.” 

Elucis enables medical professionals to quickly create, understand, and share complex patient anatomy from CTs and MRIs in an immersive 3D environment. The one-of-a-kind virtual collaboration tool lets users connect with other users in a fully functional virtual reality environment from within VR or through desktop PCs. The platform can be used to improve 3D pre-operative planning and patient consultations. 

“Virtual planning with Elucis allows me to conceptualize innovative procedures with the end product of successful cases, development of new devices, and improved education for patients and families,” said Jenny Zablah MD, Congenital Interventional Cardiologist, Colorado. 

Current and planned use cases for Elucis are expected to align to the needs of surgeons across all disciplines. 

“We’re often told that Elucis represents the most advanced offering in the mixed reality space. But with powerful image processing, modeling, and collaboration tools, it’s also a comprehensive and complete platform for serving the full suite of growing 3D needs in medicine. With FDA clearance, we’re truly excited to enable an expanding era of procedure planning and collaboration.” – Justin Sutherland, CEO 

For more information: www.realizemed.com


Related Content

News | Computed Tomography (CT)

January 30, 2023 — Photon-counting detector CT reduces the amount of contrast needed for CT angiography (CTA) while ...

Home January 30, 2023
Home
Feature | Computed Tomography (CT) | By Christine Book

According to the U.S. Centers for Disease Control and Prevention (CDC), one person dies every 37 seconds in the United ...

Home January 18, 2023
Home
News | Computed Tomography (CT)

November 17, 2022 — Cedars-Sinai investigators and colleagues have developed an artificial intelligence (AI) tool that ...

Home November 17, 2022
Home
News | Computed Tomography (CT)

November 8, 2022 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Home November 08, 2022
Home
News | Computed Tomography (CT)

November 1, 2022 — Cleerly, the company creating a new standard of care for heart disease, announced a new workflow ...

Home November 01, 2022
Home
News | Computed Tomography (CT)

August 31, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), fully automated and normalized body ...

Home August 31, 2022
Home
News | Computed Tomography (CT)

August 15, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), the combination of deep-learning ...

Home August 15, 2022
Home
News | Computed Tomography (CT)

June 16, 2022 — Xoran Technologies has recently received a patent for a modular computed tomography (CT) system assembly ...

Home June 16, 2022
Home
News | Computed Tomography (CT)

June 15, 2022 — Seven finalists have been selected for the Best Abstract Award in cardiovascular computed tomography ...

Home June 15, 2022
Home
News | Computed Tomography (CT)
March 29, 2022 – Cardiac computed tomography (CCT) is an accurate, noninvasive diagnostic test for obstructive coronary ...
Home March 29, 2022
Home
Subscribe Now